Active — Not RecruitingNot Applicable

Evaluating Stress Management Among Allogeneic HCT Caregivers

United States505 participantsStarted 2021-09-16

Plain-language summary

The purpose of the study is to understand whether different stress management interventions impact stress among HCT cancer caregivers and patients.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Caregiver Inclusion Criteria: * Caring for a patient planning to receive an allogeneic HCT at Moffitt * Intending to remain primary caregiver throughout patient treatment (i.e., will be the caregiver the majority of the time) * Able to provide informed consent * Able to read and write in English * Owns a smartphone and is willing to download the study app * Patient Inclusion Criteria: * Receiving an allogeneic HCT at the cancer center * Able to provide informed consent * Able to read and write in English Exclusion Criteria: * Under 21 years of age * Unable to provide informed consent * Unable to read and write in English * Caregiver is unable to remain primary caregiver throughout patient treatment * Patient does not receive transplant at Moffitt Cancer Center

What they're measuring

Caregiver Burden at End of Treatment

Timeframe: Up to 8 Weeks

Caregiver Burden at 2 Month Follow-up

Timeframe: 2 month follow up after end of treatment

Caregiver Burden at 6 Month Follow-up

Timeframe: 6 month follow up after end of treatment

Patient Distress at End of Treatment (CESD)

Timeframe: Up to 8 Weeks

Patient Distress at End of Treatment (GAD-7)

Timeframe: Up to 8 Weeks

Patient Distress at 2 Month Follow-up (CESD)

Timeframe: 2 Month Follow-up after end of treatment

Patient Distress at 2 Month Follow-up (GAD-7)

Timeframe: 2 Month Follow-up after end of treatment

Patient Distress at 6 Month Follow-up (CESD)

Timeframe: 6 Month Follow-up after end of treatment

Trial details

NCT IDNCT05078229

SponsorH. Lee Moffitt Cancer Center and Research Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-31

View on ClinicalTrials.gov More Burden trials

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Caregiver Burden at End of Treatment

Timeframe: Up to 8 Weeks

Caregiver Burden at 2 Month Follow-up

Timeframe: 2 month follow up after end of treatment

Caregiver Burden at 6 Month Follow-up

Timeframe: 6 month follow up after end of treatment

Patient Distress at End of Treatment (CESD)

Timeframe: Up to 8 Weeks

Patient Distress at End of Treatment (GAD-7)

Timeframe: Up to 8 Weeks

Patient Distress at 2 Month Follow-up (CESD)

Timeframe: 2 Month Follow-up after end of treatment

Patient Distress at 2 Month Follow-up (GAD-7)

Timeframe: 2 Month Follow-up after end of treatment

Patient Distress at 6 Month Follow-up (CESD)

Timeframe: 6 Month Follow-up after end of treatment